HHealthcare Read More GEMMABio Announces Clinical Trial Authorization for New SMA1 Gene TherapyNovember 25, 2025 Program deemed safe-to-proceed in Brazil with the first dosing expected within the next few months PHILADELPHIA, Nov. 24,…